{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:48:32Z","timestamp":1790340512616,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jneuroim.2008.06.028","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T16:45:39Z","timestamp":1218645939000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Thymus and Myasthenia Gravis: What can we learn from DNA microarrays?"],"prefix":"10.1016","volume":"201-202","author":[{"given":"G\u00e9raldine","family":"Cizeron-Clairac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozen","family":"Le Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lin\u00e9e","family":"Frenkian-Cuvelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Meraouna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Truffault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Bismuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha","family":"Mussot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kerlero de Rosbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.06.028_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nri2191","article-title":"CD1 antigen presentation: how it works","volume":"7","author":"Barral","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1987.tb51282.x","article-title":"The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases","volume":"505","author":"Berrih-Aknin","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/intimm\/14.4.411","article-title":"IFN-alpha\/beta enhances BCR-dependent B cell responses","volume":"14","author":"Braun","year":"2002","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib4","first-page":"187","article-title":"B- and T-cell activation in the thymus of patients with myasthenia gravis","volume":"14","author":"Cohen-Kaminsky","year":"1989","journal-title":"Thymus"},{"key":"10.1016\/j.jneuroim.2008.06.028_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-5728(89)90101-X","article-title":"Evidence of enhanced recombinant interleukin-2 sensitivity in thymic lymphocytes from patients with myasthenia gravis: possible role in autoimmune pathogenesis","volume":"24","author":"Cohen-Kaminsky","year":"1989","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib6","first-page":"33","article-title":"Myosin and actin containing cells in the human postnatal thymus","volume":"32","author":"Drenckhahn","year":"1979","journal-title":"Ultrastructural and immunohistochemical findings in normal thymus and in myasthenia gravis. Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"10.1016\/j.jneuroim.2008.06.028_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0046-8177(91)90132-9","article-title":"In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients","volume":"22","author":"Emilie","year":"1991","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/ar1002","article-title":"Neural immune pathways and their connection to inflammatory diseases","volume":"5","author":"Eskandari","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib9","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","article-title":"CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs","volume":"99","author":"Forster","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2008.06.028_bib11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/00365510310000376","article-title":"Non-pathogenic bacteria modulate colonic epithelial gene expression in germ-free mice","volume":"38","author":"Fukushima","year":"2003","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib12","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome","volume":"103","author":"Gottenberg","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2249.1991.tb05625.x","article-title":"Individual germinal centres of myasthenia gravis human thymuses contain polyclonal activated B cells that express all the Vh and Vk families","volume":"83","author":"Guigou","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib14","first-page":"4602","article-title":"In vivo T cell response to viral superantigen","volume":"156","author":"Le Bon","year":"1996","journal-title":"Selective migration rather than proliferation. J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib15","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.177.11.7868","article-title":"Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia","volume":"177","author":"Le Panse","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib16","doi-asserted-by":"crossref","DOI":"10.1196\/annals.1405.019","article-title":"Regulatory and pathogenic mechanisms in human autoimmune Myasthenia Gravis","author":"Le Panse","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","article-title":"Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status","volume":"171","author":"Leite","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib20","first-page":"2115","article-title":"Thymic B cells from myasthenia gravis patients are activated B cells","volume":"145","author":"Leprince","year":"1990","journal-title":"Phenotypic and functional analysis. J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0046-8177(78)80131-2","article-title":"Thymic hyperplasia and neoplasia: a review of current concepts","volume":"9","author":"Levine","year":"1978","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2004.01.022","article-title":"Thymic myoid cells as a myasthenogenic antigen and antigen-presenting cells","volume":"150","author":"Matsumoto","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib23","first-page":"902","article-title":"Thymus in myasthenia gravis","volume":"81","author":"Melms","year":"1988","journal-title":"Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","article-title":"The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis","volume":"108","author":"Meraouna","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2008.06.028_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2003.11.013","article-title":"Thymic myoid cells express high levels of muscle genes","volume":"148","author":"Mesnard-Rouiller","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib26","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood.V89.9.3287","article-title":"Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody","volume":"89","author":"Moulian","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2008.06.028_bib27","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.4049\/jimmunol.174.10.5941","article-title":"Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis","volume":"174","author":"Poea-Guyon","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-5728(02)00038-3","article-title":"Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis","volume":"125","author":"Roxanis","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0165-5728(00)00269-1","article-title":"Expression of metabotropic glutamate receptors in murine thymocytes and thymic stromal cells","volume":"109","author":"Storto","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib30","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.it.2005.03.002","article-title":"CD1 and MHC II find different means to the same end","volume":"26","author":"Sullivan","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2119\/2006-00107.Trevino","article-title":"DNA microarrays: a powerful genomic tool for biomedical and clinical research","volume":"13","author":"Trevino","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1750-3639.1999.tb00227.x","article-title":"Antibodies to ion channels in paraneoplastic disorders","volume":"9","author":"Vincent","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib33","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.4049\/jimmunol.157.8.3752","article-title":"Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis","volume":"157","author":"Wakkach","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib34","first-page":"1229","article-title":"Establishment of a human thymic myoid cell line","volume":"155","author":"Wakkach","year":"1999","journal-title":"Phenotypic and functional characteristics. Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2008.06.028_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0734-9750(99)00035-X","article-title":"cDNA microarray technology and its applications","volume":"18","author":"Xiang","year":"2000","journal-title":"Biotechnol. Adv."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808002063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808002063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:10:10Z","timestamp":1759047010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572808002063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":35,"alternative-id":["S0165572808002063"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.028","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymus and Myasthenia Gravis: What can we learn from DNA microarrays?","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}